Fundraising FoxAmbra BioHealth
Carlsbad, US · Founded 2014 · Delaware LLC
Find your way into Ambra BioHealth
Sign up to see every warm intro you have to Ambra BioHealth
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ambra BioHealth team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
WT
William TrebaskyExecutive
MB
Martin BrownExecutiveMartin Brown held executive positions at Elcelyx Therapeutics, Amylin Pharmaceuticals, and Eli Lilly & Company over more than 30 years in life sciences. He is Executive Officer and Director of Ambra BioHealth, which develops a system for delivering compounds to the lower gut to modulate hormones affecting satiety, metabolism, and mood.
Board
GF
Gerald FinkenBoard director
Reported raises · per SEC filings
Form D private placements$3.8M disclosed across 4 rounds · 2015–2017
▶$1.1MraisedDec 2017 · 14 investors · Other Health CareRule 506(b)
▶$1.1MraisedDec 2017 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Martin BrownExecutive Officer, Director
- Russ LebovitzDirector
- Gerald FinkenDirector
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- First sale
- Nov 2017
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
▶$960KraisedMay 2017 · 4 investors · Other Health CareRule 506(b)
▶$960KraisedMay 2017 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Martin BrownExecutive Officer, Director
- Gerald FinkenDirector
- Offering amount
- $960K
- Amount sold
- $960K
- First sale
- Apr 2017
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
▶$650KraisedSep 2016 · 6 investors · Other Health CareRule 506(b)
▶$650KraisedSep 2016 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William TrebaskyExecutive Officer, Director
- Gerald FinkenDirector
- Martin BrownExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $650K
- Minimum investment
- $5K
- Proceeds to insiders
- $144K
- First sale
- Apr 2016
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
▶$1.2MraisedFeb 2015 · 13 investors · PharmaceuticalsRule 506(b)
▶$1.2MraisedFeb 2015 · 13 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Gerald FinkenDirector
- William TrebaskyExecutive Officer, Director
- Martin BrownExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.2M
- Minimum investment
- $5K
- Proceeds to insiders
- $36K
- First sale
- Jan 2015
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Ambra BioHealth raised?
- Ambra BioHealth has disclosed $3.8M raised across 4 rounds.
- Where is Ambra BioHealth headquartered?
- Ambra BioHealth is headquartered in Carlsbad, US.